Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

MPI Research Invests in an Additional Gyrolab™ xP Workstation

Published: Wednesday, May 23, 2012
Last Updated: Wednesday, May 23, 2012
Bookmark and Share
Gyros’ nanoliter-scale immunoassay platform proves commercial success for US-based CRO.

Gyros AB has announced that MPI Research has become the first contract research organization (CRO) in North America to secure a second Gyrolab™ xP workstation, a nanoliter-scale immunoassay platform.

Data from immunoassays underpin many critical decisions within complex workflows for the development of biopharmaceuticals.

The automated, precise, nanoliter-scale immunoassay platform from Gyros enables project-specific biomarker, pharmacokinetic (PK), immunogenicity assays and impurity tests to be developed quickly, and to easily transfer the running of established assays.

Since installing its first Gyrolab xP workstation in April 2011, MPI Research has developed more than 25 novel assays using the platform. The ability to work with nanoliter volumes maximizes the number of assays that can be performed on samples that are often scarce.

Roger Hayes, PhD, Vice President and General Manager of Laboratory Sciences at MPI Research, commented: “Part of our mission is to exceed expectations, which means investing in innovative technology that can make a real difference to the way we work. We have seen great success both scientifically and commercially with the Gyrolab workstation, and look forward to building on this with additional platforms.”

Erik Walldén, CEO, Gyros, added: “We are very pleased that MPI Research has seen success with the Gyrolab platform. With the growing trend for outsourcing to CRO’s, we are also seeing these companies increasing their capacity for our technology.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Gyros Immunoassay Platform Selected by BioAgilytix Labs to Support Bioanalysis Services
Gyros AB announced that BioAgilytix Labs has invested in two Gyrolab™ xP workstations to support its bioanalysis services.
Tuesday, November 12, 2013
Gyros AB Appoints Dr. Claus Braestrup to the Board of Directors
Dr. Braestrup is a member of the Board of Directors of Bavarian Nordic A/S, Chairman of the Board of Probiodrug AG and a member of the Boards of Santaris Pharma A/S and Evolva Holding SA.
Monday, January 28, 2013
Gyros AB Appoints Dr Henrik Björkman as CTO and VP Technical Affairs
Dr Henrik Björkman will lead the R&D and product supply teams.
Monday, January 21, 2013
Gyros AB Quality Management System Receives ISO 9001:2008 Certification
Certification reassures customers that they receive consistently high standard of products and services.
Tuesday, December 18, 2012
Gyros and GE Healthcare Life Sciences Expand Asian Distribution Relationship
Gyros AB announces that GE Healthcare Life Sciences has become sole distributor for the company’s nanoliter-scale immunoassay platform in China, Taiwan and Hong Kong.
Friday, August 26, 2011
Scientific News
Toxicity Testing With Cultured Liver Cells
Microreactor replaces animal testing.
Study Validates Analysis of Copy Number Variation in Miniaturized Reaction Volumes
Data shows that accurate and reproducible CNV results can be produced with IntelliQube using the Array Tape® consumable.
Organs on Chips
Combining 3D cell culture with microfluidics, organs-on-chips could revolutionize toxicology testing for pharmaceuticals, foods, cosmetics, pesticides, and industrial chemicals.
Finding the Needle in a Microbial Haystack
After developing a novel investigational technology called PathoChip that can rapidly identify elusive microorganisms, a team of Penn Medicine researchers recently succeeded for the first time in identifying a pathogen in a patient sample, demonstrating the proof of principle that this technology can be used to identify pathogens in human disease.
Organ-on-a-Chip
In a step toward personalized drug testing, researchers coax human stem cells to form complex tissues.
Diagnosing Cancer from a Single Drop of Blood
What if a physician could effectively diagnose cancer from one drop of a patient’s blood?
Study Reveals Shared Behavior of Microbes And Electrons
Bacteria streaming through a lattice behave like electrons in a magnetic material.
Study Reveals Shared Behavior of Microbes and Electrons
Bacteria streaming through a lattice behave like electrons in a magnetic material.
Detecting When and Why Deadly Blood Clots Form
New bioinspired blood coagulation assay is more sensitive than existing assays and could one day be used to diagnose rare bleeding disorders and prevent toxic effects of anticoagulant and antiplatelet drugs.
Tracing a Cellular Family Tree
New technique allows tracking of gene expression over generations of cells as they specialize.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!